What is the targeted drug for ovarian cancer

Ovarian cancer is the third most common gynecological tumor, but the most destructive malignant tumor with the highest mortality rate. The cause of ovarian cancer has not yet been determined, but there are some clear risk factors, such as age, fertility, blood type, mental factors and environment.

It is worth noting that ovarian cancer has no obvious genetic tendency, and there has been no clear report that ovarian cancer is hereditary. As for treatment, a comprehensive treatment that emphasizes both Chinese and Western medicine is generally used. Western medicine treats the symptoms, while Chinese medicine strengthens the body and inhibits tumor growth. Chemotherapy is the most commonly used treatment method, and it has achieved certain clinical effects, but it is also very harmful to the human body, often killing 10,000 enemies and injuring 7,000 of itself. Moreover, it will also develop resistance to certain chemotherapy drugs, such as oxaliplatin and other chemotherapy drugs. Therefore, it must be supplemented with important strong treatment.

Targeted therapy for ovarian cancer is a current research focus. Many institutions have conducted in-depth research: through single-dose targeted drugs, targeted combined chemotherapy, targeted combined targeted, etc., efforts are being made to obtain more ovarian cancer treatment methods, and new discoveries have also been made in auxiliary diagnosis and prognostic factors.

Currently, targeted therapeutic drugs mainly include: targeted receptor blockers, monoclonal antibodies targeting certain specific cell markers, tumor angiogenesis inhibitors, anti-tumor vaccines, gene therapy, etc. Unfortunately, these targeted therapeutic drugs are not currently used on a large scale for ovarian cancer. It is reported that targeted therapy is good compared to other traditional therapies. The most commonly used drug for targeted therapy is Shark Capsule, which works hard to inhibit tumor blood vessel blockage. The targeted drug Shark Capsule only kills tumor blood vessels, but does not block normal blood vessels in the human body.